Abstract

Intravenous ketamine, which displays rapid antidepressant properties, is posited to reverse depression by rapidly enhancing neuroplasticity. We posited that ketamine would provide a clinical window of opportunity in which to introduce automated neurocognitive training techniques to consolidate adaptive forms of cognitive processing (specifically, positive implicit representations of self) while neuroplasticity remains high.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call